AFGVF logo

Agfa-Gevaert N.V. (AFGVF) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

AFGVF, $ (piyasa değeri 0) fiyatla Industrials işi olan Agfa-Gevaert N.V.'i temsil ediyor. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 42/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 16 Mar 2026
42/100 AI Puanı

Agfa-Gevaert N.V. (AFGVF) Endüstriyel Operasyonlar Profili

CEOPascal Juery
Çalışanlar4765
MerkezMortsel, BE
Halka Arz Yılı2009

Agfa-Gevaert NV, founded in 1867, provides imaging solutions and IT services across diverse sectors, including printing, healthcare, and industrial applications. With a global reach and a focus on both analog and digital technologies, the company caters to specialized needs in hospitals, printing companies, and industrial manufacturers.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 16 Mar 2026

Yatırım Tezi

Agfa-Gevaert NV presents a complex investment case. The company's diverse portfolio across imaging and IT solutions offers exposure to multiple sectors, including healthcare and printing. However, its negative P/E ratio of -1.00 and a negative profit margin of -6.4% indicate profitability challenges. The company's beta of 0.58 suggests lower volatility compared to the market. Growth catalysts include expansion in the digital printing and healthcare IT segments. Investors should carefully consider the company's financial performance and competitive positioning before making investment decisions.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market capitalization of $0.09 billion reflects its current valuation in the market.
  • Negative P/E ratio of -1.00 indicates the company is currently not profitable.
  • Gross margin of 30.1% shows the percentage of revenue exceeding the cost of goods sold.
  • Beta of 0.58 suggests the stock is less volatile than the overall market.
  • The company operates in four segments: Offset Solutions, Radiology Solutions, Healthcare IT, and Digital Print & Chemicals.

Rakipler & Benzerleri

Güçlü Yönler

  • Diverse product portfolio across multiple segments.
  • Global sales and distribution network.
  • Expertise in both analog and digital technologies.
  • Established brand reputation in the imaging industry.

Zayıflıklar

  • Negative profitability and P/E ratio.
  • Exposure to cyclical industries, such as printing.
  • Competition from larger and more diversified companies.
  • Dependence on specific markets and customers.

Katalizörler

  • Ongoing: Expansion in the healthcare IT market, driven by the increasing adoption of digital solutions in healthcare.
  • Ongoing: Growth in the digital printing market, fueled by the demand for customized and short-run printing.
  • Upcoming: Potential partnerships with hydrogen technology companies to develop membranes for hydrogen production.
  • Ongoing: Focus on product innovation and expansion in specialty films and materials.
  • Ongoing: Geographic expansion in emerging markets to increase global reach and revenue.

Riskler

  • Potential: Technological obsolescence in the imaging industry.
  • Potential: Economic downturns affecting demand for printing and industrial products.
  • Ongoing: Increased competition from larger and more diversified companies.
  • Potential: Regulatory changes impacting the healthcare and printing industries.
  • Ongoing: Negative profitability and P/E ratio indicating financial challenges.

Büyüme Fırsatları

  • Expansion in Healthcare IT Solutions: Agfa-Gevaert can capitalize on the growing demand for healthcare IT solutions, including picture archiving and communication systems (PACS) and hospital information systems (HIS). The global healthcare IT market is projected to reach $440.2 billion by 2026, offering significant growth potential. By focusing on integrated care solutions and expanding its customer base in hospitals and imaging centers, Agfa-Gevaert can increase its market share and revenue.
  • Growth in Digital Printing and Industrial Inks: The digital printing market is expanding rapidly, driven by the increasing demand for customized and short-run printing. Agfa-Gevaert's Digital Print & Chemicals segment can benefit from this trend by offering inkjet printers, inks, and fluids for various industrial applications. The global digital printing market is expected to reach $40.8 billion by 2026. By developing innovative ink formulations and expanding its product portfolio, Agfa-Gevaert can strengthen its position in this market.
  • Development of Hydrogen Production Membranes: Agfa-Gevaert's expertise in membrane technology can be leveraged to develop membranes for hydrogen production. The demand for hydrogen as a clean energy source is increasing, driving the need for efficient and cost-effective hydrogen production methods. The global hydrogen generation market is projected to reach $201 billion by 2030. By investing in research and development and partnering with hydrogen technology companies, Agfa-Gevaert can tap into this emerging market.
  • Focus on Specialty Films and Materials: Agfa-Gevaert's Digital Print & Chemicals segment offers specialty films for various applications, including micrography, non-destructive testing, and security documents. These films cater to niche markets with specific requirements. By focusing on product innovation and expanding its customer base in these markets, Agfa-Gevaert can generate stable revenue streams and improve its profitability.
  • Geographic Expansion in Emerging Markets: Agfa-Gevaert can expand its presence in emerging markets, where the demand for imaging solutions and IT services is growing rapidly. By establishing partnerships with local distributors and tailoring its products to meet the specific needs of these markets, Agfa-Gevaert can increase its global reach and revenue. Emerging markets offer significant growth opportunities due to their increasing healthcare spending and industrial development.

Fırsatlar

  • Expansion in healthcare IT solutions.
  • Growth in digital printing and industrial inks.
  • Development of hydrogen production membranes.
  • Geographic expansion in emerging markets.

Tehditler

  • Technological obsolescence.
  • Economic downturns.
  • Increased competition.
  • Regulatory changes.

Rekabet Avantajları

  • Established brand reputation in the imaging industry.
  • Extensive product portfolio across multiple segments.
  • Global sales and distribution network.
  • Expertise in both analog and digital technologies.

AFGVF Hakkında

Agfa-Gevaert NV, established in 1867 and headquartered in Mortsel, Belgium, has evolved from a manufacturer of photographic materials to a provider of comprehensive imaging solutions and IT services. The company operates through four primary segments: Offset Solutions, Radiology Solutions, Healthcare IT, and Digital Print & Chemicals. The Offset Solutions segment offers integrated prepress and printing solutions, including computer-to-plate systems, pressroom supplies, and workflow software. The Radiology Solutions segment provides analog and digital imaging technologies for diagnostic purposes, including X-ray film, digital radiography equipment, and image processing software. The Healthcare IT segment delivers picture archiving and communication systems, hospital information systems, and integrated care solutions. The Digital Print & Chemicals segment focuses on inkjet printers, inks, and fluids for various industrial applications, as well as specialty films and materials. Agfa-Gevaert sells its products through its own sales organization and a network of agents and representatives worldwide.

Ne Yaparlar

  • Develops and distributes analog and digital imaging systems.
  • Provides IT solutions for healthcare and industrial applications.
  • Offers integrated prepress and printing solutions for commercial, newspaper, and packaging printers.
  • Supplies X-ray film, hardcopy film, and digital radiography equipment for diagnostic imaging.
  • Delivers picture archiving and communication systems (PACS) for hospitals and imaging centers.
  • Produces inkjet printers, inks, and fluids for industrial inkjet applications.
  • Manufactures specialty films for micrography, non-destructive testing, and security documents.

İş Modeli

  • Develops and sells imaging hardware and software solutions.
  • Provides IT services and support to healthcare providers.
  • Generates revenue through sales of consumables, such as film and ink.
  • Offers maintenance and service contracts for its equipment.

Sektör Bağlamı

Agfa-Gevaert NV operates in the industrial machinery sector, which is influenced by technological advancements and economic cycles. The company faces competition from established players and new entrants in each of its segments. The healthcare IT market is experiencing growth due to the increasing adoption of digital solutions in healthcare. The printing industry is evolving with the shift towards digital printing technologies. Agfa-Gevaert's ability to innovate and adapt to these trends will be crucial for its success.

Kilit Müşteriler

  • Commercial, newspaper, and packaging printers.
  • Hospitals and imaging centers.
  • Sign and display printing companies.
  • Industrial manufacturers using inkjet printing.
  • Organizations requiring specialty films for security documents and print media.
AI Güveni: 71% Güncellendi: 16 Mar 2026

Finansallar

Grafik & Bilgi

Agfa-Gevaert N.V. (AFGVF) hisse senedi fiyatı: Price data unavailable

Son Haberler

AFGVF için son haber bulunmamaktadır.

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

AFGVF için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

AFGVF için Wall Street fiyat hedefi analizi.

MoonshotScore

42/100

Bu puan ne anlama geliyor?

MoonshotScore, AFGVF'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Pascal Juery

CEO

Pascal Juery has served as the CEO of Agfa-Gevaert since 2015. Prior to joining Agfa-Gevaert, he held various leadership positions at Rhodia and Solvay, where he gained extensive experience in the chemical and materials industries. He holds a degree in Chemical Engineering from École Polytechnique and an MBA from INSEAD.

Sicil: Under Pascal Juery's leadership, Agfa-Gevaert has focused on transforming its business model and investing in growth areas, such as healthcare IT and digital printing. He has overseen the company's efforts to streamline its operations, reduce costs, and improve its financial performance. Key milestones include the acquisition of several healthcare IT companies and the launch of new digital printing products.

AFGVF OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that Agfa-Gevaert N.V. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and performance. Investing in OTC Other stocks carries higher risks compared to stocks listed on major exchanges due to the lack of regulatory oversight and transparency.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Liquidity for AFGVF is likely limited given its OTC Other listing. Expect wider bid-ask spreads compared to major exchanges, potentially leading to higher transaction costs. Lower trading volumes may make it difficult to buy or sell large quantities of shares without significantly impacting the price. Investors should exercise caution and use limit orders to manage potential price slippage.
OTC Risk Faktörleri:
  • Limited financial disclosure increases information asymmetry.
  • Lower liquidity can lead to price volatility.
  • Higher potential for fraud and manipulation.
  • OTC Other stocks may be subject to less regulatory oversight.
  • Delisting risk if the company fails to meet minimum requirements.
Durum Tespiti Kontrol Listesi:
  • Verify the company's financial statements and audit reports.
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Review the company's legal and regulatory filings.
  • Check for any history of fraud or misconduct.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a qualified financial advisor.
Meşruiyet Sinyalleri:
  • Company has been in operation since 1867.
  • Presence in multiple segments: Offset Solutions, Radiology Solutions, Healthcare IT, and Digital Print & Chemicals.
  • Global sales and distribution network.
  • CEO with prior experience at Rhodia and Solvay.
  • The company has a substantial number of employees (4765).

AFGVF Industrials Hisse Senedi SSS

AFGVF için değerlendirilmesi gereken temel faktörler nelerdir?

Agfa-Gevaert N.V. (AFGVF) şu anda yapay zeka skoru 42/100, düşük puanı gösteriyor. Temel güçlü yan: Diverse product portfolio across multiple segments.. İzlenmesi gereken birincil risk: Potential: Technological obsolescence in the imaging industry.. Bu bir finansal tavsiye değildir.

AFGVF MoonshotScore'u nedir?

AFGVF şu anda MoonshotScore'da 42/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

AFGVF verileri ne sıklıkla güncellenir?

AFGVF fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler AFGVF hakkında ne diyor?

AFGVF için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

AFGVF'a yatırım yapmanın riskleri nelerdir?

AFGVF için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Technological obsolescence in the imaging industry.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

AFGVF'ın P/E oranı nedir?

AFGVF için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için AFGVF'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

AFGVF aşırı değerli mi, yoksa düşük değerli mi?

Agfa-Gevaert N.V. (AFGVF)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

AFGVF'ın temettü verimi nedir?

Agfa-Gevaert N.V. (AFGVF) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • OTC data may have limited availability and reliability.
  • AI analysis pending for AFGVF.
Veri Kaynakları

Popüler Hisseler